company background image
XRAY

DENTSPLY SIRONA NasdaqGS:XRAY Stock Report

Last Price

US$31.48

Market Cap

US$6.8b

7D

1.1%

1Y

-36.8%

Updated

27 Nov, 2022

Data

Company Financials +
XRAY fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance0/6
Financial Health3/6
Dividends4/6

XRAY Stock Overview

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide.

DENTSPLY SIRONA Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DENTSPLY SIRONA
Historical stock prices
Current Share PriceUS$31.48
52 Week HighUS$58.70
52 Week LowUS$26.48
Beta0.95
1 Month Change2.01%
3 Month Change-4.84%
1 Year Change-36.77%
3 Year Change-44.32%
5 Year Change-52.36%
Change since IPO2,922.08%

Recent News & Updates

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Nov 09
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona names Glenn Coleman as new CFO

Sep 22

Recent updates

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Nov 09
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Investors Will Want DENTSPLY SIRONA's (NASDAQ:XRAY) Growth In ROCE To Persist

Apr 29
Investors Will Want DENTSPLY SIRONA's (NASDAQ:XRAY) Growth In ROCE To Persist

DENTSPLY SIRONA (NASDAQ:XRAY) Seems To Use Debt Rather Sparingly

Mar 16
DENTSPLY SIRONA (NASDAQ:XRAY) Seems To Use Debt Rather Sparingly

When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Feb 26
When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 39%?

Jan 21
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 39%?

DENTSPLY SIRONA (NASDAQ:XRAY) Is Looking To Continue Growing Its Returns On Capital

Dec 17
DENTSPLY SIRONA (NASDAQ:XRAY) Is Looking To Continue Growing Its Returns On Capital

Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Nov 29
Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Nov 11
Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Returns Are Gaining Momentum At DENTSPLY SIRONA (NASDAQ:XRAY)

Sep 13
Returns Are Gaining Momentum At DENTSPLY SIRONA (NASDAQ:XRAY)

DENTSPLY SIRONA (NASDAQ:XRAY) Is Paying Out A Larger Dividend Than Last Year

Aug 08
DENTSPLY SIRONA (NASDAQ:XRAY) Is Paying Out A Larger Dividend Than Last Year

DENTSPLY SIRONA (NASDAQ:XRAY) Seems To Use Debt Quite Sensibly

Jul 26
DENTSPLY SIRONA (NASDAQ:XRAY) Seems To Use Debt Quite Sensibly

Do DENTSPLY SIRONA's (NASDAQ:XRAY) Earnings Warrant Your Attention?

Jul 12
Do DENTSPLY SIRONA's (NASDAQ:XRAY) Earnings Warrant Your Attention?

This Is The Reason Why We Think DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) CEO Deserves A Bump Up To Their Compensation

May 20
This Is The Reason Why We Think DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) CEO Deserves A Bump Up To Their Compensation

DENTSPLY SIRONA Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 09
DENTSPLY SIRONA Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 35% Below Their Intrinsic Value Estimate

Apr 19
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 35% Below Their Intrinsic Value Estimate

Does DENTSPLY SIRONA (NASDAQ:XRAY) Have A Healthy Balance Sheet?

Mar 31
Does DENTSPLY SIRONA (NASDAQ:XRAY) Have A Healthy Balance Sheet?

The Independent Director of DENTSPLY SIRONA Inc. (NASDAQ:XRAY), Gregory Lucier, Just Bought 67% More Shares

Mar 10
The Independent Director of DENTSPLY SIRONA Inc. (NASDAQ:XRAY), Gregory Lucier, Just Bought 67% More Shares

Should You Think About Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Now?

Feb 23
Should You Think About Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Now?

The Trends At DENTSPLY SIRONA (NASDAQ:XRAY) That You Should Know About

Feb 05
The Trends At DENTSPLY SIRONA (NASDAQ:XRAY) That You Should Know About

Shareholder Returns

XRAYUS Medical EquipmentUS Market
7D1.1%1.9%1.3%
1Y-36.8%-20.2%-18.5%

Return vs Industry: XRAY underperformed the US Medical Equipment industry which returned -20.2% over the past year.

Return vs Market: XRAY underperformed the US Market which returned -18.5% over the past year.

Price Volatility

Is XRAY's price volatile compared to industry and market?
XRAY volatility
XRAY Average Weekly Movement6.0%
Medical Equipment Industry Average Movement8.6%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: XRAY is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: XRAY's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
187715,000Simon Campionhttps://www.dentsplysirona.com

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

DENTSPLY SIRONA Inc. Fundamentals Summary

How do DENTSPLY SIRONA's earnings and revenue compare to its market cap?
XRAY fundamental statistics
Market CapUS$6.77b
Earnings (TTM)-US$806.00m
Revenue (TTM)US$4.06b

1.7x

P/S Ratio

-8.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
XRAY income statement (TTM)
RevenueUS$4.06b
Cost of RevenueUS$1.83b
Gross ProfitUS$2.23b
Other ExpensesUS$3.03b
Earnings-US$806.00m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-3.75
Gross Margin54.85%
Net Profit Margin-19.84%
Debt/Equity Ratio55.9%

How did XRAY perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

-13%

Payout Ratio